Author Archives: Casey Fullem

About Casey Fullem

Casey Fullem, Marketing Coordinator at Golden Helix, joined team in October of 2021. He is an analytics driven digital marketer that values tactile marketing efforts that yield return. Building a cohesive brand and executing performative marketing campaigns is his passion, alongside the slew of outdoor activities that Bozeman has to offer. Casey is largely passionate about skiing, rock climbing, whitewater kayaking and rafting, fly fishing, backpacking, and other outdoor activities that excite.

Showcasing VarSeq: Empowering Groundbreaking Genetic Research

         October 29, 2024

Our VarSeq software continues to support cutting-edge research, enabling scientists worldwide to explore the depths of genetic variants with precision and accuracy. In this blog, we highlight recent publications that leveraged VarSeq for impactful discoveries in pharmacogenomics and familial cancer studies, showcasing the vital role of our tools in advancing personalized medicine and genetic research. Thai pharmacogenomics database −2 (TPGxD-2)… Read more »

How VarSeq Powers Research in Inherited Diseases and Cancer

         September 25, 2024

Exome and genome sequencing have advanced genetic research, but data analysis remains complex. VarSeq simplifies this by helping researchers identify key genetic changes in rare diseases and cancer, improving screening and diagnosis. Here are recent customer publications that highlight VarSeq usage. Expanded carrier screening for inherited genetic disease using exome and genome sequencing The goal of this study was to… Read more »

Pioneering Precision Medicine: Recent Publications Showcasing the Impact of VarSeq

         July 30, 2024

This month, we saw overwhelming customer publications with great use cases of VarSeq. Explore the publications below of our amazing customers continuing to pioneer precision medicine. The polygenic implication of clopidogrel responsiveness: Insights from platelet reactivity analysis and next-generation sequencing Clopidogrel is widely used worldwide as an antiplatelet therapy in patients with acute coronary disease. Genetic factors influence interindividual variability… Read more »

Exploring Cutting-Edge Genetic Research with VarSeq: Recent Publications Highlighting Innovation and Discovery

         June 26, 2024

At Golden Helix, we are proud to support researchers and clinicians worldwide who push the boundaries of precision medicine. Our VarSeq software continues to be instrumental in the analysis and interpretation of genetic data, enabling groundbreaking discoveries and advancements. Recently, several papers have been published that showcase the power and versatility of VarSeq in various research domains, from neurodegenerative diseases… Read more »

Preprints, Posters, and Golden Helix Authors

         May 30, 2024

We continue to make significant contributions to the field of genomic analysis through collaborative studies, innovative software solutions, and robust data interpretation methodologies. This blog highlights four recent contributions from our team and collaborators, showcasing the breadth of our research and its implications for clinical practice. Analyzing Performance of Twist Bioscience Exome Enrichment with Spike-in CNV Backbone Panels at Various… Read more »

Golden Helix at ESHG 2024 in Berlin, Germany!

         May 21, 2024

We are excited to participate in the European Human Genetics (ESHG) 2024 conference, where we will showcase our latest advancements in genetic analysis software. Attendees can visit Booth #428 to explore tools like VarSeq, VS-CNV, VSClinical, VSPipeline, and VSWarehouse. These solutions, aligned with ACMG and AMP Guidelines, offer powerful options for genomic analysis. Live demos will highlight our newest pharmacogenomics… Read more »

Powering Precision Medicine: Golden Helix Customers Innovate with VarSeq

         May 2, 2024

Precision tools are paramount for unlocking groundbreaking discoveries in the rapidly evolving field of genetic research. We have consistently paved the way with VarSeq—an all-encompassing solution tailored for genomics professionals. This sophisticated tool not only simplifies the complexity of genomic data but also amplifies its potential to drive significant advancements in medical research and personalized care. From aiding pediatric nephrology… Read more »

Advancing Genetic Research: The Role of VarSeq and VS-CNV in Breakthrough Discoveries

         March 31, 2024

In the rapidly evolving field of genomics, innovative technologies, and methodologies are constantly being developed to enhance our understanding and diagnosis of genetic disorders. Golden Helix’s VarSeq and VS-CNV software platforms stand at the forefront of this revolution, offering powerful tools for genetic data analysis and interpretation. This blog highlights recent research endeavors where these tools have been instrumental. From… Read more »

Golden Helix VarSeq in Action – P715: Analyzing performance of the Twist exome with CNV backbone at various probe densities leveraging Golden Helix VS-CNV

         March 22, 2024

Recently, at ACMG 2024, we unveiled a collaborative research project with Twist Biosciences. By utilizing Twist Bioscience enhanced Exome 2.0 Plus Comprehensive Exome Spike-In capture panel with added backbone probes, we developed a multi-modal CNV caller designed specifically for target-capture NGS data to detect single-exon to whole-chromosome aneuploid CNV events. We are proud to say that from Golden Helix, Andreas… Read more »

CIO Bulletin – Innovation Excellence Awards

         March 12, 2024

Leading the Genomic Revolution with VarSeq Suite, Revolutionizing Precision Medicine, and Envisioning a Path for Healthier Tomorrow: Golden Helix Inc We recently were awarded by CIO Bulletin 2024, a winner of their Innovation Excellence Awards. Due to our groundbreaking contributions to the field of precision medicine, this recognition is greatly appreciated. Here’s a summary of the key highlights: In conclusion,… Read more »

Golden Helix is Launching VSPGx

         February 27, 2024

VSPGx is a pharmacogenomics interpretation software based on CPIC recommendations. The field of pharmacogenetics bridges genetics and pharmacology, with the aim of optimizing drug therapies for individual patients based on their unique genetic makeup. It has the potential to revolutionize healthcare by improving drug efficacy, reducing adverse reactions, and advancing the concept of personalized medicine moving away from a one… Read more »

We Are Heading to Toronto!

         February 27, 2024

Join Golden Helix at the American College of Medical Genetics and Genomics (ACMG) 2024 conference and discover the latest advances in genetic research. This premier event brings together leading researchers, clinicians, and industry experts to share their insights on cutting-edge topics in medical genetics. Stop by our booth for a live demo of our software, learn about the latest features,… Read more »

Exploring the Genetic Frontier: Advances in Understanding Eye Disorders

         January 30, 2024

Welcome to the exploration of groundbreaking genetic research in ophthalmology. Recent studies have unveiled fascinating insights into the complex interplay between genetics and eye diseases, offering hope and new directions for understanding and treating these conditions. From novel genetic variants linked to microphthalmia and glaucoma to the long-term implications of cataract surgery in childhood, we’re diving into the depths of… Read more »

VarSeq in Action: Deciphering Complex Genetic Puzzles in Immune Thrombocytopenia, Glaucoma, and Rare Syndromes

         December 31, 2023

In this blog, we explore the impactful applications of VarSeq in genetic research and diagnostics. Through case studies, we examine its role in diverse conditions like Immune Mediated Thrombocytopenia (ITP), glaucoma, and Cri du Chat syndrome. These studies demonstrate VarSeq’s capability in identifying genetic variants and influencing diagnosis and treatment across various medical scenarios, showcasing its crucial role in advancing… Read more »

Decoding Complex Genetics: VarSeq’s Pivotal Role in Melanoma and Autism Spectrum Disorder Research

         November 30, 2023

In the rapidly evolving field of genetic research, VarSeq software by Golden Helix stands out as a powerful tool for genetic analysis and interpretation. This is exemplified in two significant customer publications that demonstrate the versatility and impact of VarSeq in advancing our understanding of complex genetic disorders. Characterization of Potential Melanoma Predisposition Genes in High-Risk Brazilian Patients Increased genetic… Read more »

Introducing VarSeq 2.5.0: Elevating NGS Labs to New Heights

         November 9, 2023

We’re buzzing with excitement and couldn’t wait to share some groundbreaking news with our community: VarSeq 2.5.0 has officially landed, and it’s here to transform your NGS lab experience! What’s New with VarSeq 2.5.0? VarSeq has always been about innovation and pushing the boundaries, and the 2.5.0 update is no exception. We’ve listened to your feedback and supercharged VarSeq with… Read more »

Deciphering the Genetic Code of Disease: Insights from VarSeq-Analyzed Research on Human and Feline Conditions

         October 31, 2023

In the ever-evolving field of genetics, the quest to understand the intricate dance between genetic predispositions and disease manifestations continues to gain momentum. The three research papers presented here offer a glimpse into this complex interplay, each exploring the genetic underpinnings of distinct medical conditions across species. From the debilitating effects of acute retinal necrosis in humans to the life-threatening… Read more »

Emerging Insights in Medical Research: Explorations with VarSeq

         September 28, 2023

Recent advancements in medical research have been pivotal in deepening our understanding of a variety of health conditions. The utilization of tools such as VarSeq in these studies allows for comprehensive genomic analyses, thereby ensuring more accurate diagnoses and facilitating the development of targeted treatments. This bloghighlights three recent publications that have utilized VarSeq to unravel the mysteries of different… Read more »

Decoding DNA: Unraveling the Genetic Mysteries of Cancer Susceptibility

         August 31, 2023

In an era where genetics is reshaping our understanding of diseases, recent customer research publications offer invaluable insights, particularly in the realm of cancer. A study titled “Co-Occurrence of Germline Genomic Variants and Copy Number Variations in Hereditary Breast and Colorectal Cancer Patients” dives into a rare phenotype bridging hereditary colorectal and breast cancer syndromes, revealing the profound impact of… Read more »

Advancing Precision Medicine: A Spotlight on Golden Helix’s VarSeq in Genomic Research and Clinical Applications

         August 1, 2023

The field of genomics and precision medicine is rapidly evolving, bringing forth innovative diagnostic and treatment approaches. The cutting-edge techniques and technologies discussed in the following papers provide insight into how whole-exome sequencing (WES), whole-genome sequencing (WGS), and deep computational analysis are reshaping healthcare. Our spotlight is on recent customer publications featuring the study of a unique heritable form of… Read more »